Dispensing patterns and cost of glucose-lowering therapies in diabetes mellitus patients at a tertiary care hospital in Southern India

G. Shivaprakash, Akash, R. S. Nishith, A. Basu, Pallavi Shivaprakash, Prabha Adhikari, H. N. Gopalakrishna, U. P. Rathnakar

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Trends in the prescription pattern change periodically with the advent and introduction of novel drugs, changing insights and regular revision of national and international guidelines. We sought to determine the prescribing patterns and cost of antidiabetic drug in South Indian population. Retrospective collection of data in diabetic cohorts was carried. A total of 200 diabetic patients who have attended the diabetic clinic, KMC, Attavar, Mangalore were collected from the hospital records with 100 patients each in the years 2005 and 2010. The data collected for each patient was-demographic data, associated comorbidities, fasting and postprandial blood glucose levels, Hba1c, antidiabetic medications and investigations performed during each visit. Drug therapy adviced during each visit were collected and total cost per visit was calculated. Compared to diabetic patients in the year 2005 the number of diabetic patients above the age 60yr and patients with comorbidities were more in 2010. Dispensing pharmacy data indicate significant decrease in the prescription of sulfonylurea in 2010 compared to 2005. There was only marginal increase in total direct cost per visit since five years. Average cost per visit in 2005 was Rs.363 and Rs.377 in 2010. Among patients with one or more comorbidities there was 87 rupees increase in the cost per visit in 2010 compared to 2005. Prescription of monotherapy with sulfonylurea was significantly reduced in 2010 compared to prescriptions in the year 2005. The cost per visit remained same at both the years at Rs.377. Nevertheless, this is considered high particularly in developing countries like India and requires serious reforms to reduce the cost.

Original languageEnglish
Pages (from-to)671-673
Number of pages3
JournalDrug Invention Today
Volume4
Issue number12
Publication statusPublished - 01-12-2012

Fingerprint

Tertiary Healthcare
Tertiary Care Centers
India
Diabetes Mellitus
Costs and Cost Analysis
Glucose
Prescriptions
Comorbidity
Hypoglycemic Agents
Therapeutics
Hospital Records
Developing Countries
Blood Glucose
Fasting
Demography
Guidelines
Drug Therapy
Pharmaceutical Preparations
Population

All Science Journal Classification (ASJC) codes

  • Drug Discovery

Cite this

Shivaprakash, G., Akash, Nishith, R. S., Basu, A., Shivaprakash, P., Adhikari, P., ... Rathnakar, U. P. (2012). Dispensing patterns and cost of glucose-lowering therapies in diabetes mellitus patients at a tertiary care hospital in Southern India. Drug Invention Today, 4(12), 671-673.
Shivaprakash, G. ; Akash ; Nishith, R. S. ; Basu, A. ; Shivaprakash, Pallavi ; Adhikari, Prabha ; Gopalakrishna, H. N. ; Rathnakar, U. P. / Dispensing patterns and cost of glucose-lowering therapies in diabetes mellitus patients at a tertiary care hospital in Southern India. In: Drug Invention Today. 2012 ; Vol. 4, No. 12. pp. 671-673.
@article{1cd7b32541ba4580864b73309cde0885,
title = "Dispensing patterns and cost of glucose-lowering therapies in diabetes mellitus patients at a tertiary care hospital in Southern India",
abstract = "Trends in the prescription pattern change periodically with the advent and introduction of novel drugs, changing insights and regular revision of national and international guidelines. We sought to determine the prescribing patterns and cost of antidiabetic drug in South Indian population. Retrospective collection of data in diabetic cohorts was carried. A total of 200 diabetic patients who have attended the diabetic clinic, KMC, Attavar, Mangalore were collected from the hospital records with 100 patients each in the years 2005 and 2010. The data collected for each patient was-demographic data, associated comorbidities, fasting and postprandial blood glucose levels, Hba1c, antidiabetic medications and investigations performed during each visit. Drug therapy adviced during each visit were collected and total cost per visit was calculated. Compared to diabetic patients in the year 2005 the number of diabetic patients above the age 60yr and patients with comorbidities were more in 2010. Dispensing pharmacy data indicate significant decrease in the prescription of sulfonylurea in 2010 compared to 2005. There was only marginal increase in total direct cost per visit since five years. Average cost per visit in 2005 was Rs.363 and Rs.377 in 2010. Among patients with one or more comorbidities there was 87 rupees increase in the cost per visit in 2010 compared to 2005. Prescription of monotherapy with sulfonylurea was significantly reduced in 2010 compared to prescriptions in the year 2005. The cost per visit remained same at both the years at Rs.377. Nevertheless, this is considered high particularly in developing countries like India and requires serious reforms to reduce the cost.",
author = "G. Shivaprakash and Akash and Nishith, {R. S.} and A. Basu and Pallavi Shivaprakash and Prabha Adhikari and Gopalakrishna, {H. N.} and Rathnakar, {U. P.}",
year = "2012",
month = "12",
day = "1",
language = "English",
volume = "4",
pages = "671--673",
journal = "Drug Invention Today",
issn = "0975-7619",
publisher = "Association of Pharmaceutical Innovators",
number = "12",

}

Shivaprakash, G, Akash, Nishith, RS, Basu, A, Shivaprakash, P, Adhikari, P, Gopalakrishna, HN & Rathnakar, UP 2012, 'Dispensing patterns and cost of glucose-lowering therapies in diabetes mellitus patients at a tertiary care hospital in Southern India', Drug Invention Today, vol. 4, no. 12, pp. 671-673.

Dispensing patterns and cost of glucose-lowering therapies in diabetes mellitus patients at a tertiary care hospital in Southern India. / Shivaprakash, G.; Akash; Nishith, R. S.; Basu, A.; Shivaprakash, Pallavi; Adhikari, Prabha; Gopalakrishna, H. N.; Rathnakar, U. P.

In: Drug Invention Today, Vol. 4, No. 12, 01.12.2012, p. 671-673.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dispensing patterns and cost of glucose-lowering therapies in diabetes mellitus patients at a tertiary care hospital in Southern India

AU - Shivaprakash, G.

AU - Akash,

AU - Nishith, R. S.

AU - Basu, A.

AU - Shivaprakash, Pallavi

AU - Adhikari, Prabha

AU - Gopalakrishna, H. N.

AU - Rathnakar, U. P.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Trends in the prescription pattern change periodically with the advent and introduction of novel drugs, changing insights and regular revision of national and international guidelines. We sought to determine the prescribing patterns and cost of antidiabetic drug in South Indian population. Retrospective collection of data in diabetic cohorts was carried. A total of 200 diabetic patients who have attended the diabetic clinic, KMC, Attavar, Mangalore were collected from the hospital records with 100 patients each in the years 2005 and 2010. The data collected for each patient was-demographic data, associated comorbidities, fasting and postprandial blood glucose levels, Hba1c, antidiabetic medications and investigations performed during each visit. Drug therapy adviced during each visit were collected and total cost per visit was calculated. Compared to diabetic patients in the year 2005 the number of diabetic patients above the age 60yr and patients with comorbidities were more in 2010. Dispensing pharmacy data indicate significant decrease in the prescription of sulfonylurea in 2010 compared to 2005. There was only marginal increase in total direct cost per visit since five years. Average cost per visit in 2005 was Rs.363 and Rs.377 in 2010. Among patients with one or more comorbidities there was 87 rupees increase in the cost per visit in 2010 compared to 2005. Prescription of monotherapy with sulfonylurea was significantly reduced in 2010 compared to prescriptions in the year 2005. The cost per visit remained same at both the years at Rs.377. Nevertheless, this is considered high particularly in developing countries like India and requires serious reforms to reduce the cost.

AB - Trends in the prescription pattern change periodically with the advent and introduction of novel drugs, changing insights and regular revision of national and international guidelines. We sought to determine the prescribing patterns and cost of antidiabetic drug in South Indian population. Retrospective collection of data in diabetic cohorts was carried. A total of 200 diabetic patients who have attended the diabetic clinic, KMC, Attavar, Mangalore were collected from the hospital records with 100 patients each in the years 2005 and 2010. The data collected for each patient was-demographic data, associated comorbidities, fasting and postprandial blood glucose levels, Hba1c, antidiabetic medications and investigations performed during each visit. Drug therapy adviced during each visit were collected and total cost per visit was calculated. Compared to diabetic patients in the year 2005 the number of diabetic patients above the age 60yr and patients with comorbidities were more in 2010. Dispensing pharmacy data indicate significant decrease in the prescription of sulfonylurea in 2010 compared to 2005. There was only marginal increase in total direct cost per visit since five years. Average cost per visit in 2005 was Rs.363 and Rs.377 in 2010. Among patients with one or more comorbidities there was 87 rupees increase in the cost per visit in 2010 compared to 2005. Prescription of monotherapy with sulfonylurea was significantly reduced in 2010 compared to prescriptions in the year 2005. The cost per visit remained same at both the years at Rs.377. Nevertheless, this is considered high particularly in developing countries like India and requires serious reforms to reduce the cost.

UR - http://www.scopus.com/inward/record.url?scp=84876278736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876278736&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84876278736

VL - 4

SP - 671

EP - 673

JO - Drug Invention Today

JF - Drug Invention Today

SN - 0975-7619

IS - 12

ER -